158 related articles for article (PubMed ID: 33994370)
1. Chromosome 20q11.21 Amplifications in Colorectal Cancer.
Voutsadakis IA
Cancer Genomics Proteomics; 2021; 18(3 Suppl):487-496. PubMed ID: 33994370
[TBL] [Abstract][Full Text] [Related]
2. Cell Models for Chromosome 20q11.21 Amplification and Drug Sensitivities in Colorectal Cancer.
Voutsadakis IA
Medicina (Kaunas); 2021 Aug; 57(9):. PubMed ID: 34577783
[No Abstract] [Full Text] [Related]
3. Chromosome 20q Amplification Defines a Subtype of Microsatellite Stable, Left-Sided Colon Cancers with Wild-type RAS/RAF and Better Overall Survival.
Ptashkin RN; Pagan C; Yaeger R; Middha S; Shia J; O'Rourke KP; Berger MF; Wang L; Cimera R; Wang J; Klimstra DS; Saltz L; Ladanyi M; Zehir A; Hechtman JF
Mol Cancer Res; 2017 Jun; 15(6):708-713. PubMed ID: 28184012
[TBL] [Abstract][Full Text] [Related]
4. Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization.
Korn WM; Yasutake T; Kuo WL; Warren RS; Collins C; Tomita M; Gray J; Waldman FM
Genes Chromosomes Cancer; 1999 Jun; 25(2):82-90. PubMed ID: 10337990
[TBL] [Abstract][Full Text] [Related]
5. Differentially regulated genes as putative targets of amplifications at 20q in ovarian cancers.
Watanabe T; Imoto I; Katahira T; Hirasawa A; Ishiwata I; Emi M; Takayama M; Sato A; Inazawa J
Jpn J Cancer Res; 2002 Oct; 93(10):1114-22. PubMed ID: 12417041
[TBL] [Abstract][Full Text] [Related]
6. TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression.
Sillars-Hardebol AH; Carvalho B; Tijssen M; Beliën JA; de Wit M; Delis-van Diemen PM; Pontén F; van de Wiel MA; Fijneman RJ; Meijer GA
Gut; 2012 Nov; 61(11):1568-75. PubMed ID: 22207630
[TBL] [Abstract][Full Text] [Related]
7. 3q26 Amplifications in Cervical Squamous Carcinomas.
Voutsadakis IA
Curr Oncol; 2021 Jul; 28(4):2868-2880. PubMed ID: 34436017
[TBL] [Abstract][Full Text] [Related]
8. The paradox of 20q11.21 amplification in a subset of cases of myeloid malignancy with chromosome 20 deletion.
Mackinnon RN; Selan C; Wall M; Baker E; Nandurkar H; Campbell LJ
Genes Chromosomes Cancer; 2010 Nov; 49(11):998-1013. PubMed ID: 20645416
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the topoisomerase I locus in human colorectal cancer.
Boonsong A; Marsh S; Rooney PH; Stevenson DA; Cassidy J; McLeod HL
Cancer Genet Cytogenet; 2000 Aug; 121(1):56-60. PubMed ID: 10958942
[TBL] [Abstract][Full Text] [Related]
10. Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer.
Tanner MM; Tirkkonen M; Kallioniemi A; Isola J; Kuukasjärvi T; Collins C; Kowbel D; Guan XY; Trent J; Gray JW; Meltzer P; Kallioniemi OP
Cancer Res; 1996 Aug; 56(15):3441-5. PubMed ID: 8758909
[TBL] [Abstract][Full Text] [Related]
11. Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within amplified region at 20q11-q13.2 in breast cancer.
Guan XY; Xu J; Anzick SL; Zhang H; Trent JM; Meltzer PS
Cancer Res; 1996 Aug; 56(15):3446-50. PubMed ID: 8758910
[TBL] [Abstract][Full Text] [Related]
12. SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.
Woodford-Richens KL; Rowan AJ; Gorman P; Halford S; Bicknell DC; Wasan HS; Roylance RR; Bodmer WF; Tomlinson IP
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9719-23. PubMed ID: 11481457
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity of chromosome 20 in sporadic colorectal cancer.
Peng Z; Zhou C; Zhang F; Ling Y; Tang H; Bai S; Liu W; Qiu G; He L
Chin Med J (Engl); 2002 Oct; 115(10):1529-32. PubMed ID: 12490103
[TBL] [Abstract][Full Text] [Related]
14. Copy number alterations of chromosomal regions enclosing protein tyrosine phosphatase receptor-like genes in colorectal cancer.
Laczmanska I; Karpinski P; Kozlowska J; Bebenek M; Ramsey D; Sedziak T; Ziolkowski P; Sasiadek MM
Pathol Res Pract; 2014 Dec; 210(12):893-6. PubMed ID: 25169130
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and Prognosis of 8p11.23-Amplified Squamous Lung Carcinomas.
Voutsadakis IA
J Clin Med; 2023 Feb; 12(5):. PubMed ID: 36902501
[TBL] [Abstract][Full Text] [Related]
16. 20q11.1 amplification in giant-cell tumor of bone: Array CGH, FISH, and association with outcome.
Smith LT; Mayerson J; Nowak NJ; Suster D; Mohammed N; Long S; Auer H; Jones S; McKeegan C; Young G; Bos G; Plass C; Morrison C
Genes Chromosomes Cancer; 2006 Oct; 45(10):957-66. PubMed ID: 16847944
[TBL] [Abstract][Full Text] [Related]
17. 8p11.23 Amplification in Breast Cancer: Molecular Characteristics, Prognosis and Targeted Therapy.
Voutsadakis IA
J Clin Med; 2020 Sep; 9(10):. PubMed ID: 32987805
[TBL] [Abstract][Full Text] [Related]
18. BCL2L1 has a functional role in colorectal cancer and its protein expression is associated with chromosome 20q gain.
Sillars-Hardebol AH; Carvalho B; Beliën JA; de Wit M; Delis-van Diemen PM; Tijssen M; van de Wiel MA; Pontén F; Fijneman RJ; Meijer GA
J Pathol; 2012 Feb; 226(3):442-50. PubMed ID: 22009326
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal 20q gain in the DNA diploid component of aneuploid colorectal carcinomas.
De Angelis PM; Stokke T; Beigi M; Flatberg G; Enger M; Haug K; Aass HC; Schjølberg A; Andresen PA; Ariansen S; Bø AS; Mjåland O; Clausen OP
Int J Cancer; 2007 Jun; 120(12):2734-8. PubMed ID: 17354231
[TBL] [Abstract][Full Text] [Related]
20. High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization.
Nakao K; Mehta KR; Fridlyand J; Moore DH; Jain AN; Lafuente A; Wiencke JW; Terdiman JP; Waldman FM
Carcinogenesis; 2004 Aug; 25(8):1345-57. PubMed ID: 15001537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]